Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if CNTN is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
9 top institutions tracked
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 0
68 filers reported a long position in CNTN for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| ARK Investment Management LLC | $10.3M | 3.7M | -1% |
| BlackRock, Inc. | $10.3M | 3.6M | +375.7% |
| VANGUARD CAPITAL MANAGEMENT LLC | $8.5M | 3M | +566.9% |
| DRW Securities, LLC | $4.9M | 1.7M | New |
| GEODE CAPITAL MANAGEMENT, LLC | $4M | 1.4M | +223.2% |
| STATE STREET CORP | $2.6M | 929.5K | +360.4% |
| Amova Asset Management Americas, Inc. | $2M | 703.4K | -3.4% |
| Sumitomo Mitsui Trust Group, Inc. | $2M | 703.4K | -3.4% |
| Bienville Capital Management, LLC | $1.8M | 650.4K | +200% |
| VANGUARD FIDUCIARY TRUST CO | $1.2M | 421.7K | +99.5% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.